
Solara Active Pharma Sciences Ltd
NSE:SOLARA

Income Statement
Earnings Waterfall
Solara Active Pharma Sciences Ltd
Revenue
|
12.7B
INR
|
Cost of Revenue
|
-6.7B
INR
|
Gross Profit
|
6.1B
INR
|
Operating Expenses
|
-5.3B
INR
|
Operating Income
|
704.7m
INR
|
Other Expenses
|
-3.2B
INR
|
Net Income
|
-2.5B
INR
|
Income Statement
Solara Active Pharma Sciences Ltd
Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||
Revenue |
13 867
N/A
|
14 140
+2%
|
14 228
+1%
|
14 103
-1%
|
13 218
-6%
|
13 400
+1%
|
13 864
+3%
|
14 694
+6%
|
16 169
+10%
|
16 740
+4%
|
16 781
+0%
|
13 517
-19%
|
12 683
-6%
|
11 928
-6%
|
11 296
-5%
|
14 240
+26%
|
14 438
+1%
|
14 661
+2%
|
15 529
+6%
|
14 069
-9%
|
12 889
-8%
|
13 001
+1%
|
12 218
-6%
|
12 734
+4%
|
|
Gross Profit | |||||||||||||||||||||||||
Cost of Revenue |
(7 824)
|
(7 047)
|
(6 983)
|
(6 709)
|
(6 751)
|
(5 968)
|
(6 014)
|
(6 409)
|
(8 085)
|
(7 532)
|
(7 662)
|
(6 326)
|
(7 460)
|
(6 710)
|
(6 733)
|
(8 306)
|
(8 947)
|
(7 852)
|
(8 334)
|
(8 375)
|
(9 588)
|
(8 146)
|
(7 490)
|
(6 683)
|
|
Gross Profit |
6 043
N/A
|
7 093
+17%
|
7 246
+2%
|
7 394
+2%
|
6 467
-13%
|
7 432
+15%
|
7 851
+6%
|
8 286
+6%
|
8 084
-2%
|
9 208
+14%
|
9 119
-1%
|
7 191
-21%
|
5 223
-27%
|
5 218
0%
|
4 563
-13%
|
5 935
+30%
|
5 491
-7%
|
6 808
+24%
|
7 196
+6%
|
5 694
-21%
|
3 301
-42%
|
4 855
+47%
|
4 729
-3%
|
6 051
+28%
|
|
Operating Income | |||||||||||||||||||||||||
Operating Expenses |
(4 539)
|
(5 578)
|
(5 573)
|
(5 590)
|
(4 727)
|
(5 611)
|
(5 775)
|
(5 969)
|
(5 231)
|
(6 375)
|
(6 551)
|
(6 655)
|
(5 476)
|
(6 335)
|
(6 153)
|
(6 087)
|
(5 209)
|
(6 494)
|
(6 756)
|
(7 301)
|
(5 270)
|
(6 604)
|
(6 232)
|
(5 346)
|
|
Selling, General & Administrative |
(3 568)
|
(1 917)
|
(1 963)
|
(1 990)
|
(3 761)
|
(2 100)
|
(2 174)
|
(2 258)
|
(4 086)
|
(2 360)
|
(2 440)
|
(2 496)
|
(4 296)
|
(2 290)
|
(2 192)
|
(2 122)
|
(4 012)
|
(2 359)
|
(2 439)
|
(2 481)
|
(4 105)
|
(2 378)
|
(2 264)
|
(2 154)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Depreciation & Amortization |
(831)
|
(869)
|
(910)
|
(936)
|
(934)
|
(975)
|
(1 016)
|
(1 052)
|
(1 080)
|
(1 101)
|
(1 109)
|
(1 119)
|
(1 116)
|
(1 128)
|
(1 130)
|
(1 126)
|
(1 105)
|
(1 090)
|
(1 066)
|
(1 045)
|
(1 027)
|
(1 025)
|
(1 016)
|
(1 002)
|
|
Other Operating Expenses |
(140)
|
(2 793)
|
(2 700)
|
(2 664)
|
(32)
|
(2 536)
|
(2 585)
|
(2 659)
|
(65)
|
(2 913)
|
(3 003)
|
(3 040)
|
(64)
|
(2 917)
|
(2 831)
|
(2 840)
|
(91)
|
(3 045)
|
(3 252)
|
(3 775)
|
(139)
|
(3 201)
|
(2 952)
|
(2 190)
|
|
Operating Income |
1 504
N/A
|
1 515
+1%
|
1 673
+10%
|
1 804
+8%
|
1 740
-4%
|
1 821
+5%
|
2 076
+14%
|
2 317
+12%
|
2 853
+23%
|
2 834
-1%
|
2 568
-9%
|
536
-79%
|
(253)
N/A
|
(1 117)
-341%
|
(1 590)
-42%
|
(152)
+90%
|
282
N/A
|
315
+11%
|
440
+40%
|
(1 607)
N/A
|
(1 969)
-23%
|
(1 749)
+11%
|
(1 503)
+14%
|
705
N/A
|
|
Pre-Tax Income | |||||||||||||||||||||||||
Interest Income Expense |
(873)
|
(829)
|
(832)
|
(792)
|
(657)
|
(791)
|
(782)
|
(800)
|
(646)
|
(836)
|
(813)
|
(786)
|
(633)
|
(788)
|
(838)
|
(896)
|
(789)
|
(922)
|
(947)
|
(964)
|
(963)
|
(1 114)
|
(1 152)
|
(1 164)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(7)
|
(22)
|
(35)
|
(29)
|
0
|
0
|
0
|
0
|
(52)
|
(680)
|
(1 902)
|
(1 902)
|
(1 850)
|
(1 222)
|
|
Gain/Loss on Disposition of Assets |
4
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
20
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
Total Other Income |
42
|
163
|
198
|
220
|
70
|
277
|
289
|
311
|
(12)
|
301
|
273
|
237
|
18
|
211
|
215
|
239
|
63
|
176
|
151
|
84
|
(55)
|
39
|
30
|
41
|
|
Pre-Tax Income |
677
N/A
|
849
+25%
|
1 039
+22%
|
1 232
+19%
|
1 149
-7%
|
1 307
+14%
|
1 583
+21%
|
1 828
+15%
|
2 215
+21%
|
2 293
+4%
|
2 022
-12%
|
(35)
N/A
|
(911)
-2 518%
|
(1 723)
-89%
|
(2 213)
-28%
|
(809)
+63%
|
(448)
+45%
|
(431)
+4%
|
(408)
+5%
|
(3 167)
-676%
|
(4 884)
-54%
|
(4 725)
+3%
|
(4 475)
+5%
|
(1 640)
+63%
|
|
Net Income | |||||||||||||||||||||||||
Tax Provision |
(6)
|
(6)
|
(3)
|
(3)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
328
|
475
|
568
|
567
|
226
|
182
|
89
|
90
|
(785)
|
(888)
|
(888)
|
(888)
|
|
Income from Continuing Operations |
671
|
843
|
1 037
|
1 229
|
1 145
|
1 303
|
1 581
|
1 826
|
2 214
|
2 292
|
2 022
|
(35)
|
(583)
|
(1 249)
|
(1 645)
|
(242)
|
(223)
|
(249)
|
(320)
|
(3 078)
|
(5 670)
|
(5 613)
|
(5 362)
|
(2 528)
|
|
Income to Minority Interest |
1
|
1
|
2
|
2
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
(4)
|
(5)
|
(5)
|
(4)
|
0
|
1
|
1
|
|
Net Income (Common) |
595
N/A
|
835
+40%
|
1 039
+24%
|
1 231
+19%
|
1 146
-7%
|
1 304
+14%
|
1 581
+21%
|
1 826
+15%
|
2 214
+21%
|
2 293
+4%
|
2 023
-12%
|
(34)
N/A
|
(582)
-1 620%
|
(1 247)
-114%
|
(1 644)
-32%
|
(241)
+85%
|
(222)
+8%
|
(253)
-14%
|
(325)
-28%
|
(3 083)
-849%
|
(5 674)
-84%
|
(5 613)
+1%
|
(5 361)
+4%
|
(2 527)
+53%
|
|
EPS (Diluted) |
23.8
N/A
|
32.35
+36%
|
40.09
+24%
|
45.43
+13%
|
42.44
-7%
|
45.42
+7%
|
48.06
+6%
|
59.08
+23%
|
59.46
+1%
|
63.47
+7%
|
55.96
-12%
|
-0.94
N/A
|
-14.91
-1 486%
|
-34.61
-132%
|
-45.71
-32%
|
-6.41
+86%
|
-5.68
+11%
|
-6.47
-14%
|
-8.32
-29%
|
-78.92
-849%
|
-145.25
-84%
|
-145.95
0%
|
-148.9
-2%
|
-63.4
+57%
|